2024-07-01 Conversion |
2024-07-03 9:30 pm |
N/A N/A |
ALUMIS INC. |
ALMS |
Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Management VI LLC Foresite Capital Fund VI LP Labs Co-Invest V LLC Foresite Labs Management I LLC Foresite Labs Fund I L.P. 10% Owner |
11,476,484 |
$0 |
5,379,140 (Indirect) |
View |
Ownership |
2024-06-27 9:30 pm |
N/A N/A |
ALUMIS INC. |
ALMS |
Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Management VI LLC Foresite Capital Fund VI LP Labs Co-Invest V LLC Foresite Labs Management I LLC Foresite Labs Fund I L.P. 10% Owner |
0 |
$0 |
12,652,954 (Indirect) |
View |
2023-08-31 Other |
2023-08-31 5:22 pm |
N/A N/A |
PARDES BIOSCIENCES INC. |
PRDS |
Tananbaum James B. FS Development Holdings II LLC Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Fund V L.P. President and CEO 10% Owner |
1,000 |
$0 |
2,000 (Indirect) |
View |
2023-02-17 Other |
2023-02-22 2:49 pm |
N/A N/A |
Kinnate Biopharma Inc. |
KNTE |
Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC 10% Owner |
1,100,000 |
$0 |
13,038,311 (Indirect) |
View |
Ownership |
2022-06-13 5:15 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. |
THRX |
Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner |
0 |
$0 |
4,294,621 (Indirect) |
View |
2021-12-23 Option Award(A) |
2022-06-10 4:17 pm |
N/A 2031-12-22 |
PARDES BIOSCIENCES INC. |
PRDS |
Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner |
75,000 |
$0 |
75,000 (Direct) |
View |
2021-12-23 Conversion(A) |
2021-12-30 4:30 pm |
N/A N/A |
PARDES BIOSCIENCES INC. |
PRDS |
Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner |
4,941,250 |
$0 |
4,941,250 (Indirect) |
View |
2021-12-23 Option Award |
2021-12-28 4:30 pm |
N/A N/A |
PARDES BIOSCIENCES INC. |
PRDS |
Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner |
1,000,000 |
$10 |
8,761,572 (Indirect) |
View |
2021-12-23 Conversion |
2021-12-28 4:30 pm |
N/A N/A |
PARDES BIOSCIENCES INC. |
PRDS |
Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner |
4,873,750 |
$0 |
8,761,572 (Indirect) |
View |
2021-12-23 Option Award |
2021-12-28 4:30 pm |
N/A 2031-12-22 |
PARDES BIOSCIENCES INC. |
PRDS |
Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner |
7,834,072 |
$0 |
8,761,572 (Direct) |
View |
Ownership |
2021-03-25 4:08 pm |
N/A N/A |
FS Development Corp. II |
FSII |
Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC 10% Owner |
0 |
$0 |
5,633,750 (Indirect) |
View |
2021-02-05 Option Award |
2021-02-09 3:04 pm |
N/A N/A |
Gemini Therapeutics Inc. |
GMTX |
FS Development Holdings LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director by Deputization Director 10% Owner |
1,500,000 |
$10 |
3,370,250 (Direct) |
View |
2021-02-05 Conversion |
2021-02-09 3:04 pm |
N/A N/A |
Gemini Therapeutics Inc. |
GMTX |
FS Development Holdings LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director by Deputization Director 10% Owner |
2,928,750 |
$0 |
3,370,250 (Direct) |
View |
2020-12-07 Conversion |
2020-12-09 1:35 pm |
N/A N/A |
Kinnate Biopharma Inc. |
KNTE |
Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. 10% Owner |
19,675,448 |
$0 |
291,667 (Indirect) |
View |
2020-12-03 Option Award |
2020-12-04 8:57 pm |
N/A N/A |
Kinnate Biopharma Inc. |
KNTE |
Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. 10% Owner |
1,000,000 |
$20 |
125,000 (Indirect) |
View |
Ownership |
2020-12-03 06:03 am |
N/A N/A |
Kinnate Biopharma Inc. |
KNTE |
Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. 10% Owner |
0 |
$0 |
9,838,311 (Indirect) |
View |
Ownership |
2020-10-27 4:13 pm |
N/A N/A |
FS Development Corp. |
FSDC |
Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC 10% Owner |
0 |
$0 |
3,370,250 (Indirect) |
View |